Garetosmab Uses, Dosage, Side Effects and more
Garetosmab is under investigation in clinical trial NCT04577820 (Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)).
Trade Name | Garetosmab |
Generic | Garetosmab |
Garetosmab Other Names | Garetosmab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |